AstraZeneca will fall to Pfizer once the price is right, even if British politicians are jumping up and down

Only the shareholders have the ability to refuse and they’re mandated to seek the best return

When Kraft bid for Cadbury, I recall having a conversation with someone senior at the British chocolate maker as to what would be an acceptable offer.

“I reckon you’ve got 850p in your head,” I said. The Cadbury man spluttered, and tried to say there were other considerations as well. He stressed that he and his colleagues were determined to stand and fight, to do everything they could to halt the would-be US acquirer. He was not going to be drawn on a discussion about the numbers. Note, though, that he did not deny it either.

This was not rocket science on my part. All I’d done was do a ring round of a few City analysts and ask them for the figure at which they thought Cadbury shareholders would run up the white flag – or rather, the investor institutions would walk off with a fat profit, leaving the historic British firm in the hands of the US predator.

Forget the huffing and puffing, the raging about a foreigner coming in. That sort of stuff is for the politicians, unions, local communities where jobs may be threatened. They are right to be concerned – such bids are not necessarily a good thing for the UK. But from Day One, the City will have had a target number in mind. Pay that and Cadbury is yours; fall short and you won’t get it.

So it is with Pfizer and AstraZeneca. What’s the price which the AstraZeneca board is holding out for, and if it’s achieved, will see it throw in the towel, heads held high? I reckon £59-£60 a share. Already, Pfizer has tabled a bid of £50. Up it a bit more, and again, until you reach £59, and the British firm will fall. To be fair, some shareholders have indicated that they would prefer to stick with AstraZeneca, but this is what most of the City institutions are likely to be looking for.

Let’s be clear: they’re one of two sets of people who matter in this proposed takeover. The other is the Eurocrats in Brussels. This is a big enough deal to come within EU mergers regulations. Only the European Commission can block it, and it’s not clear whether it would have reason to, since the criterion by which it assesses such mergers is solely the effect on competition, not on such things as jobs or the science base.

I’ve left out another grouping; one that we British might suppose carries weight and has enormous power in these affairs. That, of course, is our own political masters at Westminster.

The truth is there is absolutely nothing they can do to prevent Pfizer coming in and grabbing AstraZeneca. At the moment there is a lot of posturing going on, with Ed Miliband, in particular, jumping up and down, accusing David Cameron of acting as “cheerleader” for the American company’s £63bn move.

But Ed, be honest now. If you were Prime Minister today, what could you do to shoo Pfizer away? The answer, as you and I well know, is precisely nothing. It’s possible that a clause could be added to the Enterprise and Regulatory Reform Act 2013, adding research and development to the types of mergers that can prompt government intervention, namely those affecting our defence interests, media, and financial stability. However, even if that were to be done, ministers would still be powerless to act since the case falls under EU jurisdiction, and would not come to them for a decision.

In theory, the UK could press to reform the EU regulations, so that mergers of this kind would be judged under different criteria. But that would take an age, and would definitely fall outside the timeframe of the mooted Pfizer-AstraZeneca marriage. If Ed Miliband is saying that, as PM, the UK would seek such a change, then good luck to him in achieving EU-wide consensus on that one.

Vince Cable knows this, too. The Business Secretary appears to be opposed to the deal, but is markedly unspecific on the point of how he, as the Cabinet member in charge of such things, could actually do anything about it. Mr Cable wants to be seen to be more caring than the Tories – and to be fair, he probably is more concerned about the impact on jobs and our R&D expertise – and he’s anxious that Labour does not present itself as the only party that backs British business. But while he says he is concerned about the bid on “public interest grounds”, there is precious little he can do to put his words into action.

Ironically, in his four years as Business Secretary, if he cared so much about this, Mr Cable could have sought to change the rules to make it more difficult for foreigners to buy up our assets. His department passed new legislation on the competition rules just last year, while the European Commission has been consulting the UK (and other countries) on reforming its merger regulations. But what has he done about it? Zero. Mr Cable even made a point of saying Lord Heseltine was wrong in his review into UK economic growth to say there should be a failsafe mechanism for UK government intervention in takeovers of key UK assets by overseas companies. It’s a bit rich of Mr Cable, now, to turn round and complain about Pfizer.

Mr Cameron is aware of all this as well. Asking the Cabinet Secretary Sir Jeremy Heywood and Treasury mandarin Sir John Kingman to assess the Pfizer plan is pure window-dressing, nothing more, nothing less. It’s the classic ruse of a PM wanting to be seen to be doing something, a ploy designed to secure some decent PR, when he knows that in reality Sir Jeremy and Sir John’s findings have no real significance whatsoever.

All the intrepid duo can do is dream up some assurances that Pfizer must sign up to in order to obtain government backing. These though, will have no legal authority.

Pfizer has thought of some commitments of its own, saying in a letter to Mr Cameron that the number of jobs in the UK will be held constant for five years, a new R&D park will still be built in Cambridge, and 20 per cent of Pfizer’s group science will be domiciled in Britain.

But the jobs guarantee is only provided unless “circumstances significantly change”; the Cambridge site was already going to be developed; and 20 per cent of the combined group’s staff would be in the UK anyway. In other words, the letter is full of platitudes and get-outs. Pfizer can tear it up four years hence and the government of the day, even one with Mr Miliband at the helm, will only be able to watch, powerless.

Pfizer’s bosses are only human. The best hope of stopping them is to scream and shout – they have no desire to be unpopular, they will crave acceptance. There are real issues at stake here and if the anti-Pfizer movement is vocal enough it may well resonate in the US giant’s boardroom.

Likewise, at least two Parliamentary select committees are gearing up to interview the Pfizer and AstraZeneca management. Again, that is not something the Pfizer folk will relish. We should, though, be under no illusion: it is only noise. The MPs can recommend as much as they like but select committees have no decision-making powers even here in the UK, still less in Brussels, so they’re in no position to head off the Pfizer purchase.

We’ve been here before, with Kraft. Its chief, Irene Rosenfeld, did not even deign to appear before MPs, such was their supposed hold over her. Public promises as to future conduct were made by her company and then it ignored them. Why? Because it can.

If Pfizer is made of similarly stern stuff, it too can behave the same way. In the end, despite a massive amount of energy, and money, expended on anti-Kraft campaigns, MPs and others taking to the ramparts, sections of the media going wild with fury, the British company fell. What was the price it went for? 850p a share. It was always going to.

AstraZeneca, sadly, is no different. Only the shareholders have the ability to refuse and they’re mandated to seek the best return on their investments for their clients, the funds in which we hold our pensions. Their decisions may or may not be good for the UK, but unless the politicians want to add policy on large mergers to the list of items to  be renegotiated with Brussels, then it is  what it is.

Start your day with The Independent, sign up for daily news emails
PROMOTED VIDEO
News
ebooksNow available in paperback
Arts and Entertainment
Tony Hughes (James Nesbitt) after his son Olly disappeared on a family holiday in France
tv
Arts and Entertainment
The Apprentice candidates Roisin Hogan, Solomon Akhtar, Mark Wright, Bianca Miller, Daniel Lassman
tvReview: But which contestants got the boot?
Arts and Entertainment
Jim Carrey and Jeff Daniels ride again in Dumb and Dumber To
filmReview: Dumb And Dumber To was a really stupid idea
Extras
indybest
Sport
Scunthorpe goalkeeper Sam Slocombe (left) is congratulated by winning penalty taker Miguel Llera (right)
football
Latest stories from i100
Have you tried new the Independent Digital Edition apps?
Independent Dating
and  

By clicking 'Search' you
are agreeing to our
Terms of Use.

iJobs Job Widget
iJobs Money & Business

Ashdown Group: Marketing Services Manager - (communications, testing, DM)

£32000 - £35000 per annum + benefits: Ashdown Group: Marketing Services Manage...

Guru Careers: Finance Account Manager

£Neg. (DOE) + Excellent Benefits: Guru Careers: A Finance Account Manager with...

Ashdown Group: Java Developer - Hertfordshire - £47,000 + bonus + benefits

£40000 - £470000 per annum + bonus: Ashdown Group: Java Developer / J2EE Devel...

Ashdown Group: Direct Marketing Manager - B2C, Financial Services - Slough

£45000 - £55000 per annum + Benefits: Ashdown Group: An exciting opportunity h...

Day In a Page

Jeb Bush vs Hillary Clinton: The power dynamics of the two first families

Jeb Bush vs Hillary Clinton

Karen Tumulty explores the power dynamics of the two first families
Stockholm is rivalling Silicon Valley with a hotbed of technology start-ups

Stockholm is rivalling Silicon Valley

The Swedish capital is home to two of the most popular video games in the world, as well as thousands of technology start-ups worth hundreds of millions of pounds – and it's all happened since 2009
Did Japanese workers really get their symbols mixed up and display Santa on a crucifix?

Crucified Santa: Urban myth refuses to die

The story goes that Japanese store workers created a life-size effigy of a smiling "Father Kurisumasu" attached to a facsimile of Our Lord's final instrument of torture
Jennifer Saunders and Kate Moss join David Walliams on set for TV adaptation of The Boy in the Dress

The Boy in the Dress: On set with the stars

Walliams' story about a boy who goes to school in a dress will be shown this Christmas
La Famille Bélier is being touted as this year's Amelie - so why are many in the deaf community outraged by it?

Deaf community outraged by La Famille Bélier

The new film tells the story of a deaf-mute farming family and is being touted as this year's Amelie
10 best high-end laptops

10 best high-end laptops

From lightweight and zippy devices to gaming beasts, we test the latest in top-spec portable computers
Michael Carberry: ‘After such a tough time, I’m not sure I will stay in the game’

Michael Carberry: ‘After such a tough time, I’m not sure I will stay in the game’

The batsman has grown disillusioned after England’s Ashes debacle and allegations linking him to the Pietersen affair
Susie Wolff: A driving force in battle for equality behind the wheel

Susie Wolff: A driving force in battle for equality behind the wheel

The Williams driver has had plenty of doubters, but hopes she will be judged by her ability in the cockpit
Adam Gemili interview: 'No abs Adam' plans to muscle in on Usain Bolt's turf

'No abs Adam' plans to muscle in on Usain Bolt's turf

After a year touched by tragedy, Adam Gemili wants to become the sixth Briton to run a sub-10sec 100m
Calls for a military mental health 'quality mark'

Homeless Veterans campaign

Expert calls for military mental health 'quality mark'
Racton Man: Analysis shows famous skeleton was a 6ft Bronze Age superman

Meet Racton Man

Analysis shows famous skeleton was a 6ft Bronze Age superman
Garden Bridge: St Paul’s adds to £175m project’s troubled waters

Garden Bridge

St Paul’s adds to £175m project’s troubled waters
Stuff your own Christmas mouse ornament: An evening class in taxidermy with a festive feel

Stuff your own Christmas mouse ornament

An evening class in taxidermy with a festive feel
Joint Enterprise: The legal doctrine which critics say has caused hundreds of miscarriages of justice

Joint Enterprise

The legal doctrine which critics say has caused hundreds of miscarriages of justice
Freud and Eros: Love, Lust and Longing at the Freud Museum: Objects of Desire

Freud and Eros

Love, Lust and Longing at the Freud Museum